The median survival time and influence factors of newly diagnosed pancreatic cancer cases of Shanghai residency during 2004–2009.

*<p>median and 95% CI was estimated using Kaplan Meier curve by each variable individually.</p>**<p>Hazard Ratio and 95% CI was estimated using multiple Cox regression model adjusted by surgical resection, age group, sex, site of tumor, TNM grade and stage.</p

the survival rate of pancreatic cancer patients among Shanghai residency underwent surgical resection, Shanghai Cancer Registry 2004–2009.

<p>Age <60: 1-year survival rate 54.8%, 3-year survival rate 19.8%, 5-year survival rate 13.9%, Age <70: 1-year survival rate 42.3%, 3-year survival rate 11.2%, 5-year survival rate 6.7%, Age>70: 1-year survival rate 40.8%, 3-year survival rate 12.3%, 5-year survival rate 6.2%.</p

The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).

*<p>Standardized by international age structure.</p

The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).

<p>The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).</p

Summary of FA values at the TB, SON, IC, MGB, AR and WHG in the SNHL and control groups.

<p>Values are presented as mean ± SD</p><p>*Statistically significant difference.</p><p>FA values measured at the TB, SON, IC, MGB, AR and WHG of the SNHL group were compared with the control group.</p><p>Summary of FA values at the TB, SON, IC, MGB, AR and WHG in the SNHL and control groups.</p

Summary of FA values at the TB, SON, IC, MGB, AR and WHG of the good/ poor outcome group of SNHL patients.

<p>Values are presented as mean±SD</p><p>*Statistically significant difference.</p><p>FA values measured at the TB, SON, IC, MGB, AR and WHG of the good outcome group of SNHL patients were compared with the poor group.</p><p>Summary of FA values at the TB, SON, IC, MGB, AR and WHG of the good/ poor outcome group of SNHL patients.</p

Clinical and audiogram data of patients.

<p>Values are presented as mean±SD.</p><p>*Statistically significant difference.</p><p>CI, cochlear implantation; ABR, auditory brainstem response; CAP, categories of auditory performance.</p><p>Clinical and audiogram data of patients.</p

Summary of MD values at the TB, SON, IC, MGB, AR and WHG in the SNHL and control groups.

<p>Values are presented as mean ± SD; MD values measured at the TB, SON, IC, MGB, AR and WHG of the SNHL group were compared with the control group.</p><p>Summary of MD values at the TB, SON, IC, MGB, AR and WHG in the SNHL and control groups.</p

Representative DT imaging of the ROIs.

<p>(a) the trapezoid body, (b) superior olivary nucleus, (c) inferior colliculus, (d) medial geniculate body, (e) the auditory radiation, (f) the white matter of Heschl's gyrus, (square box) the selected ROI.</p

Data_Sheet_1_Effect of acupuncture for non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis.doc

BackgroundAlthough non-motor symptoms of Parkinson’s disease (PD) are serious, effective treatments are still lacking. Acupuncture may have clinical benefits for non-motor symptoms of PD patients, but high-quality evidence supporting this possibility is still limited. Hence, we conducted this meta-analysis to evaluate the effect of acupuncture treatment on non-motor symptoms in patients with PD.MethodsRandomized controlled trials (RCTs) of acupuncture treatment for PD were retrieved from the following electronic databases: Medline (OVID), Embase (OVID), Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese BioMedical Literature Database, Chonqing VIP (CQVIP), and Wangfang database. Studies evaluating non-motor symptoms of PD were retrieved. Methodological quality was assessed using the Cochrane Handbook for Systematic Reviews of Interventions.ResultsA total of 27 RCTs were included, among which 8 outcomes related to non-motor symptoms were evaluated. The results showed that acupuncture combined with medication had benefits for PD-related insomnia relative to medication alone or sham acupuncture [standardized mean difference (SMD) = 0.517; 95% confidence interval (CI) = 0.242–0.793; p = 0.000], and acupuncture treatment had benefits at 8 weeks (SMD = 0.519; 95% CI = 0.181–0.857; p = 0.003). Regarding depression, acupuncture treatment was more effective (SMD = −0.353; 95% CI = −0.669 to −0.037; p = 0.029) within 2 months (SMD = −0.671; 95% CI = −1.332 to −0.011; p = 0.046). Regarding cognition, quality of life, and Unified Parkinson’s Disease Rating Scale (UPDRS) I and II scores, acupuncture treatment was effective [SMD = 0.878, 95% CI = 0.046–1.711, p = 0.039; SMD = −0.690, 95% CI = −1.226 to −0.155, p = 0.011; weighted mean difference (WMD) = −1.536, 95% CI = −2.201 to −0.871, p = 0.000; WMD = −2.071, 95% CI = −3.792 to −0.351, p = 0.018; respectively]. A significant difference was not found in terms of PD-related constipation. Only one study evaluated PD-related fatigue.ConclusionThe results of the analysis suggested that acupuncture treatment could ameliorate the symptoms of depression, quality of life, cognition, total mentation, behavior and mood, and activities of daily living in PD patients. Nevertheless, more prospective, well-designed RCTs with larger sample sizes are required to confirm our findings.</p